Skip to main navigation
Skip to search
Skip to main content
Athabasca University Home
Search content at Athabasca University
Home
Researchers
Research Outputs
Research Activities
Datasets
News Media
Research units
Assets and Initiatives
Research Projects
Research Prizes
Impacts
Inhaled magnesium sulfate in the treatment of acute asthma
Rachel Knightly
, Stephen J. Milan
, Rodney Hughes
,
Jennifer A. Knopp-Sihota
, Brian H. Rowe
, Rebecca Normansell
, Colin Powell
Faculty of Health Disciplines
St George's Hospital
Lancaster University
Sheffield Teaching Hospitals NHS Foundation Trust
University of Alberta
Cardiff University
Research output
:
Contribution to journal
›
Review article
›
peer-review
26
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhaled magnesium sulfate in the treatment of acute asthma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Asthma
100%
Nebulized Magnesium Sulfate
100%
Magnesium Sulfate
100%
Confidence Interval
58%
Ipratropium
41%
Serious Adverse Events
33%
Intervention Group
25%
Risk Ratio
25%
Hospital Admission
25%
Risk Difference
25%
Peak Expiratory Flow Rate
25%
Randomized Controlled Trial
16%
Pediatric Patients
16%
Admission to Hospital
16%
Lung Function
16%
Methodological Quality
16%
Between-groups Differences
16%
Lung Function Tests
16%
Data Extraction
8%
Cochrane
8%
Moderate to Severe
8%
Missing Data
8%
Clinically Significant
8%
Airway
8%
Risk of Bias
8%
Selection Criteria
8%
Review Update
8%
Trial Registries
8%
Review Authors
8%
Search Methods
8%
Standardized Mean Difference
8%
Life-threatening
8%
Adult Patients
8%
Patient-completed
8%
Treatment Options
8%
Placebo-controlled Trial
8%
Combination Treatment
8%
Forced Expiratory Volume in 1 Second (FEV1)
8%
Effect Estimates
8%
Asthma Exacerbation
8%
Core Outcome Set
8%
Readmission
8%
Group Risk
8%
Event Risk
8%
Trialists
8%
Pooling Effect
8%
Severe Attack
8%
Acute Exacerbation
8%
Escalation of Care
8%
Design Outcomes
8%
Vital Signs
8%
Design Definition
8%
Design Intervention
8%
Uncertain Results
8%
Systemic Steroids
8%
Pulmonary Function
8%
Historical Comparison
8%
Point Estimate
8%
Data Pooling
8%
Symptom Severity
8%
Data Security Risks
8%
Differences between Groups
8%
Specific Aims
8%
Inactive Control
8%
Online Trial
8%
Pharmacology, Toxicology and Pharmaceutical Science
Magnesium Sulfate
100%
Adverse Event
100%
Asthma
100%
Ipratropium Bromide
50%
Randomized Controlled Trial
25%
Steroids
12%
Placebo
12%
Medicine and Dentistry
Adverse Event
100%